检索

标题
作者
Use of a combined form of prostate extract and alpha-adrenoblocker in patients after transurethral resection of the prostate
Pavlov V., Kazikhinurov A., Sabirzyanov S., Kazikhinurov R., Karaguzin R.
The questionnaire of integrated assessment of male sexuality is a tool for analyzing a man's sexual functions throughout his life
Kogan M., Efremov M., Medvedev V., Anosov A., Akhokhov Z., Sinyavskaya T., Khmaruk I.
Lower urinary tract symptoms after transurethral resection of the prostate
Ergakov D., Martov A., Turin D., Andronov A.
X-RAY-GUIDED ENDOVASCULAR SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Neimark A., Tachalov M., Neimark B., Torbik D., Arzamastsev D.
VITAPROST FORTE IN THE TREAMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: PATHOGENETIC BASICS AND CLINICAL RESULTS
Kuz’min I.
Review of clinical studies on combination therapy of 5a-reductase inhibitors and аі-blockers in patients with benign prostatic hyperplasia
Spivak L., Lokshin K., Vinarov A.
The use of prostate extract preparations in patients after transurethral resection of prostate for its benign hyperplasia
Pavlov V., Kazikhinurov A., Kazikhinurov R., Sabirzyanov S., Saleeva Y., Kazikhinurova K.
Herpes viruses and human papillomavirus in prostate cancer: first results
Mikhaleva L., Kamalov А., Karpov V., Okhobotov D., Akopyan E., Shakhpazyan N., Shaparov B., Nesterova O., Martirosyan L., Ekhoyan М., Osmanov О.
Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy
Popov S., Guseinov R., Skryabin O., Orlov I., Martov A.
Multicenter randomized study of bovhyalu-ronidase azoximer (Longidaza®) in men after transuretral resection of the prostate
Kotov S., Bolotov A., Belomyttsev S., Surenkov D., Vorobyova A.
Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer
Govorov A., Vasilyev A., Pushkar D.
The role of angiotensinconverting enzyme and angiotensin II receptors of the second type in the pathogenesis of proliferative diseases of the prostate
Chibichyan M., Chernogubova E., Avetyan A., Lapteva T., Pavlenko I., Kogan M.
The comparative analysis of surgical procedures a in patients with benign prostatic hyperplasia and type 2 diabetes mellitus
Volkov S., Mikheev R., Grigoryan O., Andreeva E.
ANALYSIS OF FACTORS AFFECTING THE COMPLIANCE WITH MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA
Malkhasyan V., Rasner P., Gevorkyan A., Semenyakin I., Tedeev A., Pushkar D.
A case of successful plasma transurethral enucleationof benign prostatic hyperplasia the size of 530 cm3
Sevryukov F., Nakagawa K., Kochkin A., Volodin M., Semenychev D.
Outpatient urodynamic monitoring in patients with BPH: world and russian experience
Shaderkin I., Lebedev G., Shaderkina V., Monakov D., Spivak L., Gadzhieva Z., Gazimiev M.
Approaches to medical management of patients with high risk of progressing of benign prostatic hyperplasia depending on concomitant erectile dysfunction
Kamalov A., Takhirzade A.
TREATMENT OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Kaprin A., Kostin A., Vinogradov I., Magamadov E.
PRIMENENIE PROSTAGUT FORTE U BOL'NYKh ADENOMOY PREDSTATEL'NOY ZhELEZY S SOPUTSTVUYuShchIM KhRONIChESKIM PROSTATITOM
Avdoshin V., Pulbere S.
The results of the multicenter prospective comparative study of Fndrogel in men with endogenous testosterone deficiency and lower urinary tract symptoms, associated with benign prostate hyperplasia («Potok»)
Kogan M., Avadieva N., Gevorkyan L., Loginov Y., Metelkin A., Mitin A., Patrikeev A.
COMPARATIVE ASSESSMENT OF TREATMENTS FOR PROSTATE ADENOMA GREATER THAN 100 CM3
Orlov I., Popov S., Martov A., Gallyamov E., Malevich S., Sushina I., Grin’ E., Sanzharov A., Novikov A., Sergeev V., Kochkin A.
An observational randomized study of the efficacy and safety of the drug Longidase®, vaginal and rectal suppositories 3000 iu in the treatment of patients with symptoms of the lower urinary tract on the background of benign prostatic hyperplasia
Kuzmenko A., Kuzmenko V., Gyaurgiev T., Vinnik Y.
A comparison between enucleation of the prostate using holmium and thulium laser in volume over 80 cc: retrospective clinical study with 12-months follow-up
Popov S., Orlov I., Martov A., Malevich S., Sushina I., Grin E., Obidnyak V., Dovganskiy D., Topuzov T.
Patients with newly diagnosed benign prostatic hyperplasia
Meshkov I., Kulchavenya E., Shevchenko S., Neimark A.
Features of diagnosis and treatment of various disorders of urination by physicians of the Republic of Dagestan and other regions of the North Caucasus and Southern Federal districts
Gadzhieva Z., Kazilov Y., Alyaev Y., Aboyan I.
RISK FACTORS FOR ANTERIOR URETHRAL STRICTURES AFTER TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA
Grechenkov A., Glybochko P., Alyaev Y., Bezrukov E., Vinarov A., Butnaru D., Sukhanov R.
A multicenter, randomized, parallel, controlled, prospective, open-label study of the efficiency and safety of bovhyaluronidase azoximer in combination therapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia
Rasner P., Al-Shukri A., Shormanov I., Tazhetdinov O., Maksimova A.
ULTRASOUND INDICATORS OF THE PROSTATE, URINARY BLADDER AND UROFLOWMETRY PARAMETERS IN THE DIAGNOSIS OF INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G., Efremov N., Bolotov A.
Predictors of bladder neck contracture after transurethral procedure on the prostate
Abbosov S., Sorokin N., Kadrev A., Shomarufov A., Nesterova O., Akilov F., Kamalov A.
Economic aspects of treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
Startsev V., Dudarev V., Sevryukov F., Zabrodina N.
The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-naive patients with benign prostatic hyperplasia
Kupriyanov Y., Rasner P., Rokhlikov I., Akrikidi A., Soloviev V., Markov A., Nozdrin E., Logvinov L., Vasilevskiy R., Skrupskiy K., Pushkar D., Putilovskiy M., Epstein O.
Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms
Amdii R., Al’-Shukri A.
PREVENTION OF THROMBOHEMORRHAGIC POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Atamanova E., Andryukhin M., Vasilenko I., Makarov O.
FEATURES OF CLINICAL COURSE AND MORPHOMETRIC PARAMETERS OF BENIGN PROSTATIC HYPERPLASIA IN MEN WITH METABOLIC SYNDROME AND ANDROGEN DEFICIENCY
Tyuzikov I., Grekov E., Kalinchenko S.
POSTCOVID COMPLICATIONS IN UROLOGY. PREVENTION
Kuzmenko A., Kuzmenko V., Gyaurgiev T.
Ejaculatory disorders after surgical treatment of benign prostatic hyperplasia
Rustamov M., Galiullin O., Vinarov A.
Conservative management of benign prostatic hyperplasia: are urologists satisfied?
Govorov A.
Experimental study on the efficiency of rectal suppositories with oxidized dextran in patients with benign prostatic hyperplasia
Novikova E., Troitsky A., Ukah H., Selyatitskaya V.
Efficacy of 5a-reductase inhibitors in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia
Nizov A.
Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts
Sivkov A., Golovanov S., Zhukova L.
The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)
Loran O., Seregin A.
SILODOSIN IN THE TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA - RESULTS OF RUSSIAN MULTICENTER OBSERVATIONAL STUDY
Pushkar D., Bernikov A., Sadchenko A.
THE ROLE OF SYSTEMATIZATION OF POSTOPERATIVE COMPLICATIONS IN ASSESSING THE EFFICIENCY AND SAFETY OF SURGICAL METHODS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Giyasov S., Gafarov R., Shodmonova Z., Mukhtarov S., Akilov F.
CURRENT APPROACHES TO CONSERVATIVE TREATMENT OF MEN WITH CONCOMITANT BENIGN PROSTATIC HYPERPLASIA AND ERECTILE DYSFUNCTION
Kamalov A., Takhirzade A.
Efficiency and safety of silodosin for treatment of lower urinary tract symptoms, associated of benign prostatic hyperplasia
Krivoborodov G., Tur E.
Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice
Kuzmenko A., Gyaurgiev T., Kuzmenko G.
Treatment of patients with lower urinary tract symptoms in Moscow
Pushkar D., Rasner P., Kotenko D., Gerasimov A., Shabalkin S.
The effects of combination therapy with 5a-reductase inhibitor and a-blocker on the prognosis of BPH
Neimark A., Davydov A., Aliev R.
TRANSURETHRAL ELECTROENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA
Martov A., Ergakov D., Andronov A., Baykov N.
INTRAVESICAL PROSTATIC PROTRUSION IN DIAGNOSING INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G., Efremov N., Bolotov A.
THE USE OF PROSTADOZ IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND COEXISTENT HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA
Antonov A., Gordeev V., Fedorchuk S., Laptev D.
Therapeutic efficacy and safety of monotherapy Alfuprost® MR 10 mg/day in clinical practice
Novikov A., Shpilenya E.
The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A., Vinnik Y., Kuzmenko V., Gyaurgiev T.
EFFICIENCY OF PHOSPHODIESTERASE-5 INHIBITORS FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CONCOMITANT ERECTILE DYSFUNCTION
Kamalov A., Nizov A.
The efficacy of fesoterodine in patients after transurethral resection of the prostate
Kuz’menko A., Kuz’menko V., Gyaurgiev T.
Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines
Vinarov A., Spivak L., Mironov A.
The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination
Alyaev Y., Pshikhachev A., Perekalina A.
Treatment of erectile dysfunction following transvesical prostatectomy
Motin P., Andrjuhin M., Pulbere S., Alekseev O., Agaev N.
Ejaculatory-protective transurethral resection of the prostate
Martov A., Andronov A., Dutov S., Baykov N.
Evaluation of long-term results of the use of entomological drug in the combination therapy of patients with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A., Kuzmenko V., Gyaurgiev T., Kuzmenko G.
Evaluation of the effect of Alfuprost® MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia
Kuzmenko A., Kuzmenko V., Gyaurgiev T.
COMBINATION DRUG THERAPY IN PATIENTS WITH BPH
Kuz’menko A., Kuz’menko V., Gyaurgiev T.
TRANSABDOMINAL AND TRANSRECTAL ULTRASOUND ASSESSMENT OF INTRAVESICAL PROSTATIC PROTRUSION
Krivoborodov G., Efremov N., Bolotov A.
Our experience of holmium laser enucleation of the prostate
Kutluev M., Safiullin R.
A COMPARATIVE CHARACTERISTICS OF TREATMENT RESULTS OF PATIENS WITH BENIGN PROSTATIC HYPERPLASIA IN COMBINATION WITH HYPOGONADISM
Kamalov A., Vasilevskiy R., Okhobotov D., Neplokhov E.
Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia
Glybochko P., Alyaev Y., Pshikhachev A., Sorokin N., Dymov A.
Superselective prostatic artery embolization as a preparatory step before turp in the treatment of benign prostatic hyperplasia in patients with large prostates
Nejmark A., Nejmark B., Tachalov M., Arzamascev D., Torbik D.
Efficacy and safety of intermittent catheterization for acute urinary retention: a prospective comparative randomized study
Malkhasyan V., Kotov S., Mamaev I., Belomytcev S., Perov R., Pulbere S., Volnukhin A., Pushkar D.
Efficiency and safety of the drug adenoprosin in patients with prostate diseases. A systematic review and meta-analysis
Morozov А., Timofeeva Е., Suvorov А., Allenov S., Spivak L.
RATIONALE OF PHARMACOTHERAPY DURATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (A CLINICAL-MORPHOLOGICAL STUDY)
Sitdykova M., Tsyplakov D., Sitdykov E., Nurtdinov A.
QUALITY OF LIFE IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AFTER TURP FOR BENIGN PROSTATIC HYPERPLASIA
Pushkar D., Bernikov A., Khodyreva L., Dudareva A., Al'-Shukri S., Amdii R., Aboyan I., Shiranov K., Medvedev V., Efremov M.
Combination of a1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study
Borisov V.
Super-selective prostatic artery embolization for bph treatment
Karpov V., Kapranov S., Shaparov B., Osmolovskiy B., Kamalov D., Kamalov A.
Factors predicting the development of urinary tract disorders in prostatic hyperplasia in elderly men
Dudarev V., Startsev V.
Russian experience with Vitaprost Forte suppositories in patients with lower urinary tract symptoms and benign prostatic hyperplasia: comparative analysis of studies
Korneev I.
Monopolar transurethral enucleation of benign prostatic hyperplasia. Our initial experience
Tsarichenko D., Simberdeev R., Glybochko P., Alyaev Y., Rapoport L., Sukhanov R., Sorokin N., Enikeev D., Davydov D.
MODIFIED METHOD OF RETROPUBIC PROSTATECTOMY (RMAPE METHOD)
Veliyev E., Sokolov A., Bogdanov A., Ilyushin L.
1 - 77 的 77 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语